Page 2 - Trial Expected News Today

Capricor Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update May 13, 2021 16:05 ET | Source: Capricor Therapeutics Capricor Therapeutics -- -Data for Phase II INSPIRE Clinical Trial Expected in Third Quarter- -Plan to File IND for Multivalent Exosome-mRNA Vaccine for SARS-CoV-2 in Third Quarter- -To Host Conference Call and Webcast Today at 4:30 p.m. ET- -- LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDA...